What distinguishes pharmaceuticals from biopharmaceuticals?
The biopharmaceuticals industry was estimated to be worth $291 billion globally in 2020. It was predicted to rise to about one trillion dollars by 2030. How does biopharma differ from the conventional pharmaceutical sector, and why are biopharmaceuticals in such high demand? For a deeper look into biopharmaceutical vs. pharmaceutical and its implications for the life sciences industry, continue reading.
Read More: Biopharma
Biopharma: what is it?
Drugs that are produced by biological processes as opposed to chemical synthesis are known as biopharmaceuticals. From multiple sclerosis to cancer, they may be used to treat a wide range of illnesses. In fact, certain biologics are even utilized as life-saving therapies.
Innovation is emphasized here, but it's not the ...